Argenica Therapeutics Advances Stroke Trial Progress

TipRanksDec 9 19:58 ET

Argenica Therapeutics' Phase 2 Stroke Drug Trial Hits Major Milestone | ASX:AGN, OTC:OTCMKTS: AGNTF

Proactive InvestorsNov 6 06:38 ET

Argenica Therapeutics Schedules 2024 AGM

TipRanksOct 10 21:18 ET

Analysts Offer Insights on Healthcare Companies: Xencor (XNCR), Argenica Therapeutics Ltd (AU:AGN) and Bio-Rad Laboratories (BIO)

TipRanksOct 8 05:02 ET · Ratings

Argenica Therapeutics Posts Positive Studies Results Required by US FDA for IND Application, Says Euroz Hartleys

MT NewswiresSep 26 19:22 ET

Petra Capital Keeps Their Buy Rating on Argenica Therapeutics Ltd (AGN)

TipRanksSep 11 19:35 ET · Ratings